DRD2

DRD2

Target · GPCR

DRD2 Dopamine receptor D2 · D2R

DRD2 (dopamine receptor D2, also known as D2R) is a G protein-coupled receptor for dopamine, the catecholamine neurotransmitter often described as the brain's 'reward chemical'. It couples to G(i)/G(o) proteins and inhibits adenylate cyclase activity. Browse Assay Genie's current range of DRD2 research reagents below, or read on for the biology behind the target.

Postsynaptic membrane receptorG(i)/G(o)-coupled GPCRLinked to myoclonus dystonia
443 aa
Protein length
~51 kDa
Molecular weight
11q23.2
Gene locus
Class A GPCR
Receptor class
Target information

What is DRD2 (dopamine receptor D2)?

DRD2 is a G protein-coupled receptor for dopamine. Dopamine binding causes a conformational change that triggers signalling through guanine nucleotide-binding proteins and modulates downstream effectors such as adenylate cyclase. Dopamine receptors fall into two categories: DRD2, together with DRD3 and DRD4, is a D2-type receptor coupled to G(i)/G(o) proteins that inhibit adenylate cyclase, whereas the D1-type receptors DRD1 and DRD5 couple to G(s) and activate it. In the central nervous system, DRD2 is mainly coupled to G(o)/GNAO1.

D1- and D2-type receptors have antagonistic effects, particularly in the striatum, where they govern voluntary movement and reward: D1-type receptors generally stimulate neural activity and promote action, while D2-type receptors tend to inhibit neural activity and suppress movement. DRD1 and DRD2 are the most abundant dopamine receptors in the central nervous system, especially in the basal ganglia and prefrontal cortex. DRD2 contributes to risky decision-making by modulating reward sensitivity and executive control, and its activation in nucleus accumbens cells leads to increased risk-taking and impulsivity.

DRD2 signalling is not limited to G(i)/G(o). In neurons it can form a heteromer with the ghrelin receptor GHSR, which acts as a coreceptor and promotes G(q) coupling, regulating defecation. In intestinal epithelial cells it also acts as a receptor for tryptophan-derived metabolites from the gut microbiota, triggering phospholipase-C-dependent signalling that supports colonisation resistance. It further promotes postnatal regression of retinal hyaloid vessels by suppressing VEGFR2/KDR activity downstream of OPN5, and acts as a receptor for the psychedelic drug LSD. The DRD2 gene belongs to the G protein-coupled receptor 1 family. A missense mutation causes myoclonus dystonia, other mutations have been associated with schizophrenia, and alternative splicing yields two transcript variants encoding different isoforms.

Neuroscience and reward

DRD2 modulates reward sensitivity, motivation and reinforcement learning, making it central to studies of dopaminergic circuits in the striatum and prefrontal cortex.

Movement disorders

D2-type receptors suppress movement in the striatum, and a DRD2 missense mutation causes myoclonus dystonia, linking the receptor to motor control research.

Psychiatric disease research

Mutations in the DRD2 gene have been associated with schizophrenia, and the receptor's role in risk-taking and impulsivity informs behavioural studies.

GPCR signalling and gut biology

DRD2 couples to G(i)/G(o) and, with GHSR, to G(q), and responds to microbiota-derived tryptophan metabolites in intestinal epithelium.

Background

DRD2 frequently asked questions

What does DRD2 do?

DRD2 is a dopamine-activated G protein-coupled receptor that couples mainly to G(i)/G(o) proteins and inhibits adenylate cyclase. In the striatum it tends to inhibit neural activity and suppress movement, and it contributes to reward sensitivity, motivation and decision-making.

What are the other names and isoforms of DRD2?

DRD2 is the HGNC symbol for dopamine receptor D2, also abbreviated D2R. NCBI Gene reports that alternative splicing produces two transcript variants encoding different isoforms, and a third variant has been described whose status as normal or aberrant is undetermined.

Is DRD2 conserved and linked to disease?

Orthologs are annotated in mouse and rat, both named Drd2. In humans, a missense mutation in the gene causes myoclonus dystonia and other mutations have been associated with schizophrenia. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other dopamine receptors, including the D2-type family members DRD3 and DRD4 and the D1-type receptor DRD1.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P14416; product specifications from Assay Genie datasheets.

DRD2 Product listing